User login

Enter your username and password here in order to log in on the website:

Forgot your password?

Press releases

05.01.2021

Regulatory Announcement: SYNLAB to prepay term loan tranches due 2022 and 2024

SYNLAB Bondco Plc ("SYNLAB") today announced that it intends to prepay all outstanding borrowings under its senior facility agreement dated 12 September 2017 (as amended from time to time, the "2017 Term Loan B ... 

05.01.2021

SYNLAB substantially completes divestment of Analytics & Services business to SGS

SYNLAB is now focussing on its core medical activities and drives further growth SYNLAB CEO: “This transaction adds great value to both SYNLAB and A&S. SYNLAB is now able to fully focus on its core medical activities, while ... 

07.12.2020

Regulatory Announcement: SYNLAB updates FY 2020 outlook

SYNLAB BONDCO PLC (“SYNLAB”) today updated the outlook for its FY 2020 performance to indicate that it estimates that Adjusted EBITDA will exceed € 550M.  

25.11.2020

Regulatory Announcement: South East London Pathology Partnership

[SYNLAB BONDCO PLC]/[SYNLAB UNSECURED BONDCO PLC] (“the Company”) confirms that a Completion Agreement between SYNLAB and Guy’s & St Thomas’ NHS Foundation Trust and King's College Hospital NHS Foundation Trust (“the Trusts”) ... 

19.11.2020

Regulatory Announcement: SYNLAB to launch a debt refinancing transaction aiming at proceeds of €385,000,000

SYNLAB Bondco Plc ("SYNLAB") today announced that it is preparing the launch of a debt refinancing transaction aiming to raise up to an aggregate principal amount of €385,000,000 through a new term loan facility, ... 

10.11.2020

SYNLAB agrees to sell Analytics & Services business to SGS

• Transaction enables SYNLAB to fully focus on its core medical activities and drive further growth • SYNLAB CEO: “The transaction creates great opportunities for all involved. While SYNLAB is  concentrating on its core ... 

10.11.2020

Regulatory Announcement: SYNLAB agrees to sell Analytics & Services business to SGS

SYNLAB Bondco Plc ("SYNLAB") announces the signing of an agreement to sell SYNLAB Group’s Analytics & Services (A&S) unit to SGS SA. The proceeds of the sale will remain in the group for future use. A&S is ... 

06.10.2020

SYNLAB expanding testing capacities to meet increasing demand in Europe for SARS-CoV-2 testing

• Over the course of the past six months, SYNLAB has been responding to requests for testing from different EU countries. • Recently, SYNLAB entered into an agreement with the Ministry of Health, Welfare and Sport of the ... 

05.08.2020

UEFA and SYNLAB work together to ensure the resumption of the UEFA competitions and matches in a safe environment

• SYNLAB appointed as “UEFA Laboratory Diagnostics Provider 2020/2021” for SARS-CoV-2 testing• UEFA and SYNLAB have established a rigorous testing procedure to create an as safe as possible environment for players, officials and ... 

19.05.2020

SYNLAB Bondco PLC completes offering of €850,000,000 Senior Secured Floating Rate Notes due 2025

“SYNLAB Bondco PLC announced today that it completed its previously announced offering of senior secured floating rate notes due 2025 (the "Notes"). The Notes will pay interest at a rate equal to three-month EURIBOR (with a 0% ...